Susan K. Kelby

Lenalidomide monotherapy in chemotherapy-naive, castration-resistant prostate cancer patients: final results of a phase II study.

C. Nabhan, D. Villines, T. Lestingi, 2014, Clinical genitourinary cancer.

Erlotinib has moderate single-agent activity in chemotherapy-naïve castration-resistant prostate cancer: final results of a phase II trial.

C. Nabhan, S. Newman, J. Bitran, 2009, Urology.

Medical Oncology Erlotinib Has Moderate Single-agent Activity in Chemotherapy-naïve Castration-resistant Prostate Cancer: Final Results of a Phase II Trial

C. Nabhan, S. Newman, J. Bitran, 2009 .

Incorporating Caring Theory into Personal and Professional Nursing Practice to Improve Perception of Care

Mary E. Desmond, Susan K. Kelby, S. Horn,, 2014, International Journal for Human Caring.